Q4 2024 · 13F-HR
Deep Track Capital, LPholdings as filed
Filed 2025-02-14 · accession 0001856083-25-000001
$2.68B
Reported value
63
Positions
2024-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 268158201 | DVAX | DYNAVAX TECHNOLOGIES CORP | $227.2M | 8.47% | 17,791,486 | Common | SOLE |
| 40131M109 | GH | GUARDANT HEALTH INC | $196.1M | 7.31% | 6,419,566 | Common | SOLE |
| 46116X101 | ITCIEUR | INTRA-CELLULAR THERAPIES INC | $167.0M | 6.23% | 2,000,000 | Common | SOLE |
| 45258J102 | IMVT | IMMUNOVANT INC | $148.6M | 5.54% | 6,000,000 | Common | SOLE |
| 03753U106 | APLSUSD | APELLIS PHARMACEUTICALS INC | $136.4M | 5.09% | 4,274,921 | Common | SOLE |
| 85205L107 | SWTXUSD | SPRINGWORKS THERAPEUTICS INC | $125.0M | 4.66% | 3,460,756 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $117.6M | 4.39% | 2,500,000 | Common | SOLE |
| 67576A100 | OCUL | OCULAR THERAPEUTIX INC | $109.6M | 4.09% | 12,836,282 | Common | SOLE |
| 92790C104 | VRDN | VIRIDIAN THERAPEUTICS INC | $86.7M | 3.23% | 4,522,741 | Common | SOLE |
| 729139105 | PLRX | PLIANT THERAPEUTICS INC | $78.7M | 2.93% | 5,972,257 | Common | SOLE |
| 86366E106 | GPCR | STRUCTURE THERAPEUTICS INC | $75.9M | 2.83% | 2,800,000 | Common | SOLE |
| 462222100 | IONS | IONIS PHARMACEUTICALS INC | $67.6M | 2.52% | 1,933,928 | Common | SOLE |
| 67080M103 | NRIX | NURIX THERAPEUTICS INC | $56.5M | 2.11% | 3,000,000 | Common | SOLE |
| 55287L101 | MBX | MBX BIOSCIENCES INC | $55.6M | 2.08% | 3,018,935 | Common | SOLE |
| 282559103 | ETNBGBP | 89BIO INC | $50.7M | 1.89% | 6,478,249 | Common | SOLE |
| 413197104 | HRMY | HARMONY BIOSCIENCES HLDGS IN | $49.9M | 1.86% | 1,450,000 | Common | SOLE |
| 26818M108 | DYN | DYNE THERAPEUTICS INC | $47.1M | 1.76% | 2,000,000 | Common | SOLE |
| 81734D104 | SEPN | SEPTERNA INC | $43.8M | 1.63% | 1,912,929 | Common | SOLE |
| 640979100 | NMRA | NEUMORA THERAPEUTICS INC. | $42.4M | 1.58% | 4,000,000 | Common | SOLE |
| 372303206 | GMAB | GENMAB A/S | $41.7M | 1.56% | 2,000,000 | Common | SOLE |
| 00973Y108 | AKRO | AKERO THERAPEUTICS INC | $41.5M | 1.55% | 1,490,000 | Common | SOLE |
| 925050106 | VRNA | VERONA PHARMA PLC | $39.5M | 1.47% | 850,000 | Common | SOLE |
| 15117B202 | CLDX | CELLDEX THERAPEUTICS INC NEW | $38.9M | 1.45% | 1,540,132 | Common | SOLE |
| 74366E102 | PTGX | PROTAGONIST THERAPEUTICS INC | $38.6M | 1.44% | 1,000,000 | Common | SOLE |
| 00182C103 | ANIP | ANI PHARMACEUTICALS INC | $35.9M | 1.34% | 649,042 | Common | SOLE |
| 055477103 | BCAX | BICARA THERAPEUTICS INC | $34.8M | 1.30% | 2,000,000 | Common | SOLE |
| 05280R100 | AUTL | AUTOLUS THERAPEUTICS PLC | $33.4M | 1.25% | 14,218,903 | Common | SOLE |
| 500946108 | KRRO | KORRO BIO INC | $33.3M | 1.24% | 874,614 | Common | SOLE |
| 880881107 | 430 | TERNS PHARMACEUTICALS INC | $30.9M | 1.15% | 5,576,558 | Common | SOLE |
| 29286M105 | — | ENGENE HOLDINGS INC | $30.3M | 1.13% | 4,557,575 | Common | SOLE |
| 90400D108 | RARE | ULTRAGENYX PHARMACEUTICAL IN | $27.5M | 1.03% | 653,513 | Common | SOLE |
| 00370M103 | ABVX | ABIVAX SA | $26.2M | 0.98% | 3,579,209 | Common | SOLE |
| 152309100 | CNTA | CENTESSA PHARMACEUTICALS PLC | $22.6M | 0.84% | 1,350,000 | Common | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $22.5M | 0.84% | 819,162 | Common | SOLE |
| 36315X101 | LKFT | GALAPAGOS NV | $21.5M | 0.80% | 780,778 | Common | SOLE |
| 68062P106 | OLMA | OLEMA PHARMACEUTICALS INC | $20.1M | 0.75% | 3,442,833 | Common | SOLE |
| 60255C885 | BRD1EUR | MIND MEDICINE MINDMED INC | $19.6M | 0.73% | 2,816,594 | Common | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $19.0M | 0.71% | 710,421 | Common | SOLE |
| 088786108 | BCYC | BICYCLE THERAPEUTICS PLC | $17.9M | 0.67% | 1,276,081 | Common | SOLE |
| 91678A107 | UPB | UPSTREAM BIO INC | $16.4M | 0.61% | 1,000,000 | Common | SOLE |
| 670002401 | NVAX | NOVAVAX INC | $16.1M | 0.60% | 2,000,000 | Common | SOLE |
| 45258D105 | IMCR | IMMUNOCORE HLDGS PLC | $15.3M | 0.57% | 519,376 | Common | SOLE |
| 687604108 | ORKA | ORUKA THERAPEUTICS INC | $14.5M | 0.54% | 750,000 | Common | SOLE |
| 374163103 | GERN | GERON CORP | $14.2M | 0.53% | 4,011,287 | Common | SOLE |
| 23256X407 | HELP | CYBIN INC | $13.5M | 0.50% | 1,529,987 | Common | SOLE |
| 640979100 | NMRA | NEUMORA THERAPEUTICS INC. | $12.6M | 0.47% | 1,189,800 | CALL | SOLE |
| 98401F105 | XNCR | XENCOR INC | $11.5M | 0.43% | 500,000 | Common | SOLE |
| 01626L204 | ALGS | ALIGOS THERAPEUTICS INC | $9.7M | 0.36% | 244,110 | Common | SOLE |
| 75382E109 | — | RAPT THERAPEUTICS INC | $9.5M | 0.35% | 6,011,380 | Common | SOLE |
| G9TY5A101 | ZURA | ZURA BIO LTD | $8.2M | 0.31% | 3,283,783 | Common | SOLE |
| 21077P108 | CNTX | CONTEXT THERAPEUTICS INC | $7.8M | 0.29% | 7,419,355 | Common | SOLE |
| 01671P100 | ALLKGUSD | ALLAKOS INC | $6.9M | 0.26% | 5,704,282 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $6.6M | 0.25% | 169,132 | Common | SOLE |
| 05338F306 | AVTX | AVALO THERAPEUTICS INC | $6.4M | 0.24% | 867,000 | Common | SOLE |
| 45773H409 | INO | INOVIO PHARMACEUTICALS INC | $5.7M | 0.21% | 3,119,162 | Common | SOLE |
| 75915K309 | RGLS | REGULUS THERAPEUTICS INC | $5.2M | 0.19% | 3,262,564 | Common | SOLE |
| 00773J202 | SYRE | SPYRE THERAPEUTICS INC | $5.1M | 0.19% | 219,015 | Common | SOLE |
| 00534A102 | IVVD | INVIVYD INC | $4.7M | 0.18% | 10,689,603 | Common | SOLE |
| 68277Q105 | OKUR | ONKURE THERAPEUTICS INC | $4.5M | 0.17% | 523,989 | Common | SOLE |
| 35104E100 | FDMT | 4D MOLECULAR THERAPEUTICS IN | $3.4M | 0.13% | 609,900 | Common | SOLE |
| 28658R106 | CLYM | CLIMB BIO INC | $1.9M | 0.07% | 1,040,115 | Common | SOLE |
| 640268108 | NKTREUR | NEKTAR THERAPEUTICS | $1.8M | 0.07% | 1,975,998 | Common | SOLE |
| 14817C107 | FLNA | CASSAVA SCIENCES INC | $1.2M | 0.04% | 500,000 | PUT | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.